We are working on a new vaccine development approach that leverages Okinawa's unique environment.
Our company is engaged in various businesses centered around vaccine development, including antibody drug development, diagnostic drug development, and adjuvant development. These businesses are derived from related academic fields such as infectious disease science, pathogenic microbiology, immunology, vaccinology, and protein engineering. Since the development of vaccines leads to the development of antibodies and diagnostic drugs, we are broadening the scope of our business while linking all these areas together. 【Business Overview】 ■ Development of recombinant protein vaccines for infectious diseases ■ Development of adjuvants (immune enhancers) ■ Development of antibody drugs ■ Development of diagnostic drugs such as immunochromatography (ICT) *For more details, please download the PDF or contact us.
Inquire About This Product
basic information
【Features】 ■ Strong expertise in early vaccine development technology ■ Focus on subunit vaccine development *For more details, please download the PDF or contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（1）
Download All Catalogs
Company information
Jectus Innovators Co., Ltd. is a bio consulting company certified by the National University Corporation, University of the Ryukyus, primarily engaged in the development of infectious disease vaccines. Currently, we are expanding our business focusing on vaccine development, antibody drug development, diagnostic drug development, and adjuvant development.